Robert J Clifford1, Uzo Chukwuma2, Michael E Sparks1, Douglas Richesson1, Charlotte V Neumann2, Paige E Waterman3, Jacob Moran-Gilad4, Michael D Julius1, Mary K Hinkle1, Emil P Lesho5. 1. Multidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, Maryland. 2. EpiData Center Department, Navy and Marine Corps Public Health Center, Portsmouth, Virginia. 3. Global Emerging Infections Surveillance, Armed Forces Health Surveillance Center, Silver Spring, Maryland. 4. Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. 5. Infectious Diseases Unit, Rochester Regional Health, Rochester, New York.
Abstract
BACKGROUND: Governments and health care regulators now require hospitals and nursing homes to establish programs to monitor and report antimicrobial consumption and resistance. However, additional resources were not provided. We sought to develop an approach for monitoring antimicrobial resistance and consumption that health care systems can implement with minimal added costs or modifications to existing diagnostic and informatics infrastructure. METHODS: Using (1) the electronic laboratory information system of a nationwide managed care network, (2) the 3 most widely used commercial microbiology diagnostic platforms, and (3) Staphylococcus aureus, one of the most common causes of infections worldwide, as a prototype, we validated the approach dubbed "SAVANT" for Semi-Automated Visualization and ANalysis of Trends. SAVANT leverages 3 analytical methods (time series analysis, the autoregressive integrated moving average, and generalized linear regression) on either commercial or open source software to report trends in antistaphylococcal use and resistance. RESULTS: All laboratory results from January 2010 through December 2015 from an annual average of 9.2 million health care beneficiaries were queried. Inpatient and outpatient prescription rates were calculated for 8 key antistaphylococcal compounds. Trends and relationships of antistaphylococcal consumption and resistance among 81 840 unique S. aureus isolates from >6.5 million cultures were revealed. CONCLUSIONS: Using existing or freely available resources, SAVANT was successfully implemented across a complex and geographically dispersed 280-hospital network, bridging a critical gap between medical informatics, large-scale data analytics, and mandatory reporting of health care quality metrics.
BACKGROUND: Governments and health care regulators now require hospitals and nursing homes to establish programs to monitor and report antimicrobial consumption and resistance. However, additional resources were not provided. We sought to develop an approach for monitoring antimicrobial resistance and consumption that health care systems can implement with minimal added costs or modifications to existing diagnostic and informatics infrastructure. METHODS: Using (1) the electronic laboratory information system of a nationwide managed care network, (2) the 3 most widely used commercial microbiology diagnostic platforms, and (3) Staphylococcus aureus, one of the most common causes of infections worldwide, as a prototype, we validated the approach dubbed "SAVANT" for Semi-Automated Visualization and ANalysis of Trends. SAVANT leverages 3 analytical methods (time series analysis, the autoregressive integrated moving average, and generalized linear regression) on either commercial or open source software to report trends in antistaphylococcal use and resistance. RESULTS: All laboratory results from January 2010 through December 2015 from an annual average of 9.2 million health care beneficiaries were queried. Inpatient and outpatient prescription rates were calculated for 8 key antistaphylococcal compounds. Trends and relationships of antistaphylococcal consumption and resistance among 81 840 unique S. aureus isolates from >6.5 million cultures were revealed. CONCLUSIONS: Using existing or freely available resources, SAVANT was successfully implemented across a complex and geographically dispersed 280-hospital network, bridging a critical gap between medical informatics, large-scale data analytics, and mandatory reporting of health care quality metrics.
Entities:
Keywords:
Staphylococcus aureus; antibiotic consumption and resistance; antimicrobial stewardship; informatics
Authors: Natasha E Holmes; John D Turnidge; Wendy J Munckhof; James O Robinson; Tony M Korman; Matthew V N O'Sullivan; Tara L Anderson; Sally A Roberts; Wei Gao; Keryn J Christiansen; Geoffrey W Coombs; Paul D R Johnson; Benjamin P Howden Journal: J Infect Dis Date: 2011-08-01 Impact factor: 5.226
Authors: Stephen P Hawser; Samuel K Bouchillon; Daryl J Hoban; Michael Dowzicky; Tim Babinchak Journal: Int J Antimicrob Agents Date: 2011-01-15 Impact factor: 5.283
Authors: Philip M Polgreen; Ming Yang; Jennifer L Kuntz; Ramanan Laxminarayan; Joseph E Cavanaugh Journal: Infect Control Hosp Epidemiol Date: 2011-07 Impact factor: 3.254
Authors: Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer Journal: JAMA Date: 2005-06-22 Impact factor: 56.272
Authors: Timothy J Whitman; Rachel K Herlihy; Carey D Schlett; Patrick R Murray; Greg A Grandits; Anuradha Ganesan; Maya Brown; James D Mancuso; William B Adams; David R Tribble Journal: Infect Control Hosp Epidemiol Date: 2010-10-28 Impact factor: 3.254
Authors: Michael W Ellis; Matthew E Griffith; David P Dooley; Joseph C McLean; James H Jorgensen; Jan E Patterson; Kepler A Davis; Joshua S Hawley; Jason A Regules; Robert G Rivard; Paula J Gray; Julia M Ceremuga; Mary A Dejoseph; Duane R Hospenthal Journal: Antimicrob Agents Chemother Date: 2007-08-06 Impact factor: 5.191